Download Files:
CCT365623
SKU
HY-124674-Get quote
Category Reference compound
Tags Cancer, Lipoxygenase, Metabolic Enzyme/Protease
Products Details
Product Description
– CCT365623 is a potent and orally active LOX inhibitor with an IC50 of 0.9 μM. CCT365623 has potent anti-metastatic efficacy in vivo[1].
Web ID
– HY-124674
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C18H17NO4S3
CAS Number
– 2126134-01-6
Molecular Weight
– 407.53
SMILES
– NCC1=CC=C(S(=O)(C2=CC(C3=CC=CC=C3)=CC(S(=O)(C)=O)=C2)=O)S1
Clinical Information
– No Development Reported
Research Area
– cancer
Solubility
– 10 mM in DMSO
Target
– Lipoxygenase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.